Surgery News and Research

RSS

Positive results for unprotected left main coronary artery PCI with drug-eluting stents

Patients with normal left ventricular function who undergo elective unprotected left main coronary artery (ULMCA) percutaneous coronary intervention (PCI) with drug-eluting stents (DES) had favorable outcomes according to new research. Results of the multicenter, retrospective study are reported in the June issue of Catheterization and Cardiovascular Interventions, a journal published by Wiley-Blackwell on behalf of The Society for Cardiovascular Angiography and Interventions (SCAI).

22 Jun 2011

Study finds PCI safe and feasible option for End-Stage Liver Disease patients with significant heart disease

A small, retrospective study determined that percutaneous coronary intervention (PCI) was safe in patients with significant coronary artery disease (CAD) who were referred for liver transplantation. Larger studies are needed to determine the effectiveness of angioplasty in patients with end-stage liver disease (ESLD).

22 Jun 2011

FDA approves ProStrakan's Rectiv for pain associated with anal fissures

ProStrakan Group plc, a subsidiary of Kyowa Hakko Kirin Co. Ltd., and an international specialty pharmaceutical company, today announces that it has received approval from the U.S. Food and Drug Administration (FDA) for Rectiv™ (nitroglycerin) Ointment 0.4 % for the treatment of moderate to severe pain associated with chronic anal fissures.

22 Jun 2011

Innovative Nail after Lengthening method can extend short thighbone by 26 centimeters

The MedUni Vienna's University Department of Trauma Surgery at Vienna General Hospital is a leader in the field of treatment of traumatic bone defects caused by accidents. A severely shortened thighbone as the result of an accident has now been able to be extended by using the innovative NAL method, creating an increase of 26 centimetres in only eight months.

22 Jun 2011

Endotis commences EP217609 Phase IIa study in patients undergoing open-heart surgery

Endotis Pharma, a world leader in the development of neutralizable anticoagulants, today announced enrolment of the first patients into a Phase IIa study using EP217609 and its specific antidote avidin to manage coagulation during open-heart surgery.

22 Jun 2011

State roundup: N.J. Gov. Christie's big health care changes

The state Senate voted 24-15 to pass legislation that will force public employees to pay more for their health insurance and pension. The vote, after hours of speeches from lawmakers on both sides, leaves only the Assembly to sign off on the bill that was a focal piece of Gov. Chris Christie's agenda.

22 Jun 2011

Gastric bypass surgery reduces inflammation linked with cancer and diabetes

New research shows that gastric bypass significantly reduces the inflammation associated with diseases including cancer and diabetes - more proof of the overall health benefits of such surgery beyond weight loss.

22 Jun 2011

ImmunoCellular Therapeutics receives U.S. patent for cancer vaccine technology

ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, announced the issuance of a U.S. patent relating to a technology for the treatment of cancer for which the Company holds an exclusive, worldwide license.

22 Jun 2011

CEL-SCI announces results from Multikine Phase II trial on head and neck cancer

CEL-SCI Corporation announced today data from its Phase II clinical studies which showed that its lead drug Multikine was able to lower cholesterol in studies involving 120 head and neck cancer patients.

22 Jun 2011

First Edition: June 21, 2011

In today's headlines, the latest on the debt-reduction talks, the next chapter in the saga surrounding a McKinsey insurance survey and the details of the Obama administration's effort to tout the health law's prreventive care benefits.

22 Jun 2011

African-Americans more likely to die from thyroid cancer than whites

African-Americans have fewer incidences of thyroid cancer but have a more advanced form of the disease once they receive a diagnosis — and are more likely to die from it, according to a new study.

21 Jun 2011

Fluorescent signature discovery helps identify parathyroid glands during endocrine surgery

The parathyroid glands - four small organs the size of grains of rice located at the back of the throat - glow with a natural fluorescence in the near infrared region of the spectrum.

21 Jun 2011

HSS orthopedic surgeon earns recognition for research on metabolic bone disease

Joseph M. Lane, M.D., an orthopedic surgeon nationally recognized for his work in metabolic bone disease, will receive the Lifetime Achievement Award at the hospital's 28th Annual Tribute Dinner on Monday, June 20, for his innovative research on bone disease and the use of bisphosphonates in treating osteoporosis. Brian Williams, anchor of Nightly News on NBC, will serve as toastmaster.

21 Jun 2011

Black patients with heart attack wait longer at hospitals to get life-saving procedures

Black patients having a heart attack wait longer at hospitals than white patients to get advanced procedures that will restore blood flow to their hearts, according to a University of Michigan Health System study.

21 Jun 2011

MedShape develops larger sizes of ExoShape CL interference fixation device

MedShape Solutions, Inc., the industry leader in innovative shape memory orthopedic devices, today announced it has developed new, larger sizes of its ExoShape CL, a two-part PEEK Altera™ interference fixation device that simplifies and improves soft tissue graft fixation during anterior cruciate ligament (ACL) reconstructive surgery.

20 Jun 2011

Genetic biomarker may help identify patients at increased risk of bypass surgery

Outcomes of bypass surgery to repair blocked arteries in the legs tend to be better in the roughly one-in-five people who have inherited a specific genetic variation from both parents, according to a study presented at the late-breaking clinical trials session of the Vascular Annual Meeting in Chicago on June 18, 2011.

20 Jun 2011

Hardin Memorial Hospital selects ProVation Order Sets

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Hardin Memorial Hospital has selected ProVation® Order Sets, powered by UpToDate® Decision Support, as the organization's electronic order set solution.

20 Jun 2011

Teleflex, Amerinet sign deal for VasoNova Vascular Positioning System

Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, has announced the addition of VasoNova Vascular Positioning System to its existing Peripherally Inserted Central Catheters agreement with Amerinet. The agreement began May 1, 2011 and runs through April 30, 2014.

20 Jun 2011

Zilver PTX stent more effective than PTA for treatment of femoral artery lesions

Results of a prospective, randomized trial indicate that when treating femoral artery (SFA) lesions, the Zilver PTX Paclitaxel-Eluting Stent shows sustained effectiveness compared to percutaneous transluminal angioplasty, even in diabetic patients.

20 Jun 2011

Positive results from vismodegib Phase II study on advanced basal cell carcinoma

Genentech, a member of the Roche Group, announced today that a pivotal Phase II study with vismodegib showed positive results in people with advanced basal cell carcinoma (BCC) for whom surgery is considered inappropriate.

20 Jun 2011

Surgery News and Research

Positive results for unprotected left main coronary artery PCI with drug-eluting stents

Study finds PCI safe and feasible option for End-Stage Liver Disease patients with significant heart disease

FDA approves ProStrakan's Rectiv for pain associated with anal fissures

Innovative Nail after Lengthening method can extend short thighbone by 26 centimeters

Endotis commences EP217609 Phase IIa study in patients undergoing open-heart surgery

State roundup: N.J. Gov. Christie's big health care changes

Gastric bypass surgery reduces inflammation linked with cancer and diabetes

ImmunoCellular Therapeutics receives U.S. patent for cancer vaccine technology

CEL-SCI announces results from Multikine Phase II trial on head and neck cancer

First Edition: June 21, 2011

African-Americans more likely to die from thyroid cancer than whites

Fluorescent signature discovery helps identify parathyroid glands during endocrine surgery

HSS orthopedic surgeon earns recognition for research on metabolic bone disease

Black patients with heart attack wait longer at hospitals to get life-saving procedures

MedShape develops larger sizes of ExoShape CL interference fixation device

Genetic biomarker may help identify patients at increased risk of bypass surgery

Hardin Memorial Hospital selects ProVation Order Sets

Teleflex, Amerinet sign deal for VasoNova Vascular Positioning System

Zilver PTX stent more effective than PTA for treatment of femoral artery lesions

Positive results from vismodegib Phase II study on advanced basal cell carcinoma

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News